Transforming IBD Care

Thank you to all our attendees, faculty, committee members, poster presenters, sponsors, exhibitors and partners for making the 2023 Crohn’s & Colitis Congress® a great success.

We look forward to seeing you January 25–27, 2024, in Las Vegas.

Transforming IBD Care

Join your colleagues from around the world and across the entire spectrum of clinical care and science at the premier conference on inflammatory bowel disease (IBD). Don’t miss all the excitement!

The Crohn’s & Colitis Congress®, a partnership of the Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA), will take place virtually on January 20-22, 2022.   


2022 Crohn's & Colitis Congress Goes Virtual

The Crohn’s & Colitis Foundation and AGA have cancelled in-person programming due to the challenges the coronavirus omicron variant outbreak places on the medical community. In order to have the safest and most educational meeting, all Crohn’s & Colitis Congress programming will be held virtually on January 20-22. 

Speakers, moderators and poster presenters will receive more details by email later this week about your virtual participation.

Exhibitors will be contacted directly by a member of Congress management for further details. 

Attendees: All registrations will be converted to virtual and housing reservations will be cancelled.

We look forward to a dynamic and educational virtual and on-demand experience.  Thank you for your patience with this transition. We share our best wishes for your health and safety.



Important Dates

Abstract Notifications: Monday, December 5, 2022

Advanced Registration Deadline: Wednesday, December 14, 2022

Important Dates


Registration Opens: Tuesday, September 27
Early Bird Registration Deadline: Wednesday, November 2
Advanced Registration Deadline: Friday, December 16

Abstract Submission

Abstract Submission Opened: Monday, September 12
Abstract Submission Deadline: Friday, October 21
Abstract Notifications: Monday, December 5

You can still register to join the live meeting. If you miss anything, the on-demand programming will be released on February 1, 2021, and be available for 90 days.

Why You Should Attend the Crohn’s & Colitis Congress

Drs. Jamie Kinnucan shares why she is excited to attend the Congress.

2023 Crohn's & Colitis Congress Chairs

Peter D. R. Higgins, MD, PhD, AGAF

Co-Chair, Organizing Committee
University of Michigan

Laura E. H. Raffals, MD, MS

Co-Chair, Organizing Committee
Mayo Clinic

Supporting Organizations

The 2023 Crohn’s & Colitis Congress was supported by an educational grant from: 

Ferring Pharmaceuticals, Inc.



Salix Pharmaceuticals, Inc.

Takeda Pharmaceuticals U.S.A., Inc.

Bristol Myers Squibb

Pfizer Inc.

Salix Pharmaceuticals, a division of Bausch Health US, LLC

Takeda Pharmaceuticals U.S.A., Inc.


The 2023 Crohn’s & Colitis Congress was partnered with:

Media Partners

The 2023 Crohn’s & Colitis Congress was partnered with: